Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers

Masaaki Nagatake, Hirotaka Osada, Masashi Kondo, Kosaku Uchida, Masayuki Nishio, Kaoru Shimokata, Toshitada Takahashi, Takashi Takahashi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Accumulating evidence suggests that altered DNA methylation may play a rule in the oncogenesis of human neoplasms, including lung cancer. The presence of aberrant hypermethylations at 3p, 9p, 11p, and 17p, which are known to be hot spots for allele loss in lung cancers, is suggested to be a reflection of the existence of tumor suppressor genes in these chromosomal regions. In the present study, we investigated the methylation status of the Rb locus at 13q14 as well as that of the bcl-2 locus at 18q21 in 134 lung cancer specimens, representing all major histological subtypes. As a result, 18q21 was identified to be the fifth chromosomal region affected by frequent tumor-specific aberrant hypermethylation in lung cancers. The occurrence of aberrant hypermethylation at the bcl-2 locus at 18q21 was restricted to non- small cell lung cancers, and among non-small cell lung cancers, such epigenetic aberrations were observed most frequently in adenocarcinomas without any association with bcl-2 expression. Interestingly, allelic loss at the bcl-2 locus was also seen in 40% (7 of 17 informative cases) of adenocarcinomas; this frequency was also the highest among values for the various histological subtypes of lung cancers. These results suggest thai aberrant hypermethylation at the bcl-2 locus may be a reflection of a putative tumor suppressor gene residing at 18q21, and aberrant hypermethylation might play a role in its inactivation. In contrast, altered methylation status of the Rb locus appears to be quite rare in lung cancers, if present at all.

Original languageEnglish
Pages (from-to)1886-1891
Number of pages6
JournalCancer Research
Volume56
Issue number8
Publication statusPublished - 15-04-1996

Fingerprint

Lung Neoplasms
Tumor Suppressor Genes
Non-Small Cell Lung Carcinoma
Methylation
Adenocarcinoma
Loss of Heterozygosity
DNA Methylation
Epigenomics
Neoplasms
Carcinogenesis
Alleles

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nagatake, M., Osada, H., Kondo, M., Uchida, K., Nishio, M., Shimokata, K., ... Takahashi, T. (1996). Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Cancer Research, 56(8), 1886-1891.
Nagatake, Masaaki ; Osada, Hirotaka ; Kondo, Masashi ; Uchida, Kosaku ; Nishio, Masayuki ; Shimokata, Kaoru ; Takahashi, Toshitada ; Takahashi, Takashi. / Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. In: Cancer Research. 1996 ; Vol. 56, No. 8. pp. 1886-1891.
@article{e231e5785b81439a95ee155b7041cba7,
title = "Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers",
abstract = "Accumulating evidence suggests that altered DNA methylation may play a rule in the oncogenesis of human neoplasms, including lung cancer. The presence of aberrant hypermethylations at 3p, 9p, 11p, and 17p, which are known to be hot spots for allele loss in lung cancers, is suggested to be a reflection of the existence of tumor suppressor genes in these chromosomal regions. In the present study, we investigated the methylation status of the Rb locus at 13q14 as well as that of the bcl-2 locus at 18q21 in 134 lung cancer specimens, representing all major histological subtypes. As a result, 18q21 was identified to be the fifth chromosomal region affected by frequent tumor-specific aberrant hypermethylation in lung cancers. The occurrence of aberrant hypermethylation at the bcl-2 locus at 18q21 was restricted to non- small cell lung cancers, and among non-small cell lung cancers, such epigenetic aberrations were observed most frequently in adenocarcinomas without any association with bcl-2 expression. Interestingly, allelic loss at the bcl-2 locus was also seen in 40{\%} (7 of 17 informative cases) of adenocarcinomas; this frequency was also the highest among values for the various histological subtypes of lung cancers. These results suggest thai aberrant hypermethylation at the bcl-2 locus may be a reflection of a putative tumor suppressor gene residing at 18q21, and aberrant hypermethylation might play a role in its inactivation. In contrast, altered methylation status of the Rb locus appears to be quite rare in lung cancers, if present at all.",
author = "Masaaki Nagatake and Hirotaka Osada and Masashi Kondo and Kosaku Uchida and Masayuki Nishio and Kaoru Shimokata and Toshitada Takahashi and Takashi Takahashi",
year = "1996",
month = "4",
day = "15",
language = "English",
volume = "56",
pages = "1886--1891",
journal = "Cancer Research",
issn = "0008-5472",
number = "8",

}

Nagatake, M, Osada, H, Kondo, M, Uchida, K, Nishio, M, Shimokata, K, Takahashi, T & Takahashi, T 1996, 'Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers', Cancer Research, vol. 56, no. 8, pp. 1886-1891.

Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. / Nagatake, Masaaki; Osada, Hirotaka; Kondo, Masashi; Uchida, Kosaku; Nishio, Masayuki; Shimokata, Kaoru; Takahashi, Toshitada; Takahashi, Takashi.

In: Cancer Research, Vol. 56, No. 8, 15.04.1996, p. 1886-1891.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers

AU - Nagatake, Masaaki

AU - Osada, Hirotaka

AU - Kondo, Masashi

AU - Uchida, Kosaku

AU - Nishio, Masayuki

AU - Shimokata, Kaoru

AU - Takahashi, Toshitada

AU - Takahashi, Takashi

PY - 1996/4/15

Y1 - 1996/4/15

N2 - Accumulating evidence suggests that altered DNA methylation may play a rule in the oncogenesis of human neoplasms, including lung cancer. The presence of aberrant hypermethylations at 3p, 9p, 11p, and 17p, which are known to be hot spots for allele loss in lung cancers, is suggested to be a reflection of the existence of tumor suppressor genes in these chromosomal regions. In the present study, we investigated the methylation status of the Rb locus at 13q14 as well as that of the bcl-2 locus at 18q21 in 134 lung cancer specimens, representing all major histological subtypes. As a result, 18q21 was identified to be the fifth chromosomal region affected by frequent tumor-specific aberrant hypermethylation in lung cancers. The occurrence of aberrant hypermethylation at the bcl-2 locus at 18q21 was restricted to non- small cell lung cancers, and among non-small cell lung cancers, such epigenetic aberrations were observed most frequently in adenocarcinomas without any association with bcl-2 expression. Interestingly, allelic loss at the bcl-2 locus was also seen in 40% (7 of 17 informative cases) of adenocarcinomas; this frequency was also the highest among values for the various histological subtypes of lung cancers. These results suggest thai aberrant hypermethylation at the bcl-2 locus may be a reflection of a putative tumor suppressor gene residing at 18q21, and aberrant hypermethylation might play a role in its inactivation. In contrast, altered methylation status of the Rb locus appears to be quite rare in lung cancers, if present at all.

AB - Accumulating evidence suggests that altered DNA methylation may play a rule in the oncogenesis of human neoplasms, including lung cancer. The presence of aberrant hypermethylations at 3p, 9p, 11p, and 17p, which are known to be hot spots for allele loss in lung cancers, is suggested to be a reflection of the existence of tumor suppressor genes in these chromosomal regions. In the present study, we investigated the methylation status of the Rb locus at 13q14 as well as that of the bcl-2 locus at 18q21 in 134 lung cancer specimens, representing all major histological subtypes. As a result, 18q21 was identified to be the fifth chromosomal region affected by frequent tumor-specific aberrant hypermethylation in lung cancers. The occurrence of aberrant hypermethylation at the bcl-2 locus at 18q21 was restricted to non- small cell lung cancers, and among non-small cell lung cancers, such epigenetic aberrations were observed most frequently in adenocarcinomas without any association with bcl-2 expression. Interestingly, allelic loss at the bcl-2 locus was also seen in 40% (7 of 17 informative cases) of adenocarcinomas; this frequency was also the highest among values for the various histological subtypes of lung cancers. These results suggest thai aberrant hypermethylation at the bcl-2 locus may be a reflection of a putative tumor suppressor gene residing at 18q21, and aberrant hypermethylation might play a role in its inactivation. In contrast, altered methylation status of the Rb locus appears to be quite rare in lung cancers, if present at all.

UR - http://www.scopus.com/inward/record.url?scp=0029970218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029970218&partnerID=8YFLogxK

M3 - Article

C2 - 8620509

AN - SCOPUS:0029970218

VL - 56

SP - 1886

EP - 1891

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -

Nagatake M, Osada H, Kondo M, Uchida K, Nishio M, Shimokata K et al. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Cancer Research. 1996 Apr 15;56(8):1886-1891.